Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-02-01 @ 8:43 PM
Study NCT ID:
NCT05243550
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-04
First Post:
2022-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Sponsor:
UroGen Pharma Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-02
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-07
First Submit QC Date:
None
Study First Post Date:
2022-02-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-04
Results First Submit QC Date:
None
Results First Post Date:
2024-11-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-30
Last Update Post Date:
2024-11-04
Last Update Post Date Type:
ACTUAL